Calithera Biosciences News

Calithera Biosciences | CT ORDER: Confidential Treatment Order

Jun 13, 2023 08:53

Calithera Biosciences | DEFM14A: Definitive proxy statement relating to merger or acquisition

Jun 6, 2023 05:16

Calithera Biosciences | PREM14A: Preliminary proxy statements relating to merger or acquisition

May 27, 2023 04:26

Calithera Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(0.0%),Takeda Ventures, Inc(0.0%)

May 26, 2023 19:08

Calithera Biosciences | 4: Statement of changes in beneficial ownership of securities-Other TAKEDA PHARMACEUTICAL CO LTD

May 26, 2023 19:08

Calithera Biosciences | DEFA14A: Others

May 20, 2023 08:50

Calithera Biosciences: FY2022 Annual Report

10-K | Calithera Biosciences, Inc. (0001496671) (Filer)

Mar 31, 2023 05:38

Calithera Biosciences | EFFECT: Others

Mar 20, 2023 12:15

Calithera Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Mar 15, 2023 04:15

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:13

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:12

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:11

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:10

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:09

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:08

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:07

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:06

Calithera Biosciences | S-8 POS: S-8 POS

Mar 15, 2023 04:04

Calithera Biosciences | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 15, 2023 04:02

Calithera Biosciences | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Mar 3, 2023 23:45